In line with this potential profibrotic role of PAR-1 during diabetes, we recently showed that PAR-1 deficient mice develop less glomerulopathy during streptozotocin (STZ)-induced type 1 diabetes. The gene discussed is F2R; the disease is glomerular disorder.